Literature DB >> 12116250

Leukocyte adhesion deficiency (LAD) type II/carbohydrate deficient glycoprotein (CDG) IIc founder effect and genotype/phenotype correlation.

Amos Etzioni1, Laura Sturla, Anthony Antonellis, Eric D Green, Ruth Gershoni-Baruch, Patricia M Berninsone, Carlos B Hirschberg, Michela Tonetti.   

Abstract

Leukocyte adhesion deficiency (LAD) type II is a rare autosomal recessive syndrome characterized by recurrent infections, typical dysmorphic features, the Bombay blood phenotype and severe growth and psychomotor retardation. It is attributed to a general absence of fucosylated glycans on the cell surface. Three Arab Israeli patients and one Turkish child have been reported so far. The primary defect in a specific GDP-L-fucose transporter of the Golgi apparatus has been disclosed recently. All three children reported by us are homozygous for one single founder mutation, different from that reported in the Turkish child. The amount of mRNA of the GDP-L-fucose transporter in cells from Arab patients and their parents are comparable to controls. Genotype/phenotype correlation studies show that the two different mutations are distinguished by differences in response to fucose supplementation and in the clinical phenotypes. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12116250     DOI: 10.1002/ajmg.10423

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  22 in total

Review 1.  Golgi nucleotide sugar transport and leukocyte adhesion deficiency II.

Authors:  C B Hirschberg
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

Review 2.  Hematologically important mutations: leukocyte adhesion deficiency (first update).

Authors:  Edith van de Vijver; Anne Maddalena; Özden Sanal; Steven M Holland; Gulbu Uzel; Manisha Madkaikar; Martin de Boer; Karin van Leeuwen; M Yavuz Köker; Nima Parvaneh; Alain Fischer; S K Alex Law; Nigel Klein; F Ilhan Tezcan; Ekrem Unal; Turkan Patiroglu; Bernd H Belohradsky; Klaus Schwartz; Raz Somech; Taco W Kuijpers; Dirk Roos
Journal:  Blood Cells Mol Dis       Date:  2011-11-30       Impact factor: 3.039

3.  Negative feedback regulation of Wnt signaling via N-linked fucosylation in zebrafish.

Authors:  Lei Feng; Hao Jiang; Peng Wu; Florence L Marlow
Journal:  Dev Biol       Date:  2014-09-18       Impact factor: 3.582

Review 4.  The role of nucleotide sugar transporters in development of eukaryotes.

Authors:  Li Liu; Yu-Xin Xu; Carlos B Hirschberg
Journal:  Semin Cell Dev Biol       Date:  2010-02-06       Impact factor: 7.727

Review 5.  Biological functions of fucose in mammals.

Authors:  Michael Schneider; Esam Al-Shareffi; Robert S Haltiwanger
Journal:  Glycobiology       Date:  2017-07-01       Impact factor: 4.313

Review 6.  Infections in patients with inherited defects in phagocytic function.

Authors:  Timothy Andrews; Kathleen E Sullivan
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

7.  Neural and synaptic defects in slytherin, a zebrafish model for human congenital disorders of glycosylation.

Authors:  Yuanquan Song; Jason R Willer; Paul C Scherer; Jessica A Panzer; Amy Kugath; Emmanuel Skordalakes; Ronald G Gregg; Gregory B Willer; Rita J Balice-Gordon
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

8.  The Drosophila neurally altered carbohydrate mutant has a defective Golgi GDP-fucose transporter.

Authors:  Christoph Geisler; Varshika Kotu; Mary Sharrow; Dubravko Rendić; Gerald Pöltl; Michael Tiemeyer; Iain B H Wilson; Donald L Jarvis
Journal:  J Biol Chem       Date:  2012-06-28       Impact factor: 5.157

Review 9.  Lessons from rare maladies: leukocyte adhesion deficiency syndromes.

Authors:  Estelle S Harris; Andrew S Weyrich; Guy A Zimmerman
Journal:  Curr Opin Hematol       Date:  2013-01       Impact factor: 3.284

Review 10.  Leukocyte adhesion deficiency type II: long-term follow-up and review of the literature.

Authors:  Yael Gazit; Adi Mory; Amos Etzioni; Moshe Frydman; Oded Scheuerman; Ruth Gershoni-Baruch; Ben-Zion Garty
Journal:  J Clin Immunol       Date:  2010-01-23       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.